SCHEMBL5281629

SCHEMBL5281629

CC(C)=NN=c1n(C)c2ccc(Cl)cc2n1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PSMB8 P28062 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
MAPT P10636 4/20 0.34
KMT2A Q03164 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
PKM P14618 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
HPGD P15428 2/20 0.34
CYP2C19 P33261 2/20 0.34
RXFP1 Q9HBX9 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CXCR3 P49682 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283139 0.81 MAPT (0.35) LMNAMAPTKMT2AALDH1A1MEN1
SCHEMBL5284940 0.80 MCL1 (0.37) MAPTKMT2AALDH1A1MEN1HPGD
SCHEMBL5288241 0.78 SMN1; SMN2 (0.41) L3MBTL1MAPTKMT2AALDH1A1MEN1
SCHEMBL4613974 0.75 PSMB8 (0.40) LMNAL3MBTL1PSMB8GABRA1GABRG2
SCHEMBL5281140 0.74 MAPT (0.44) LMNAL3MBTL1MAPTKMT2AALDH1A1
SCHEMBL5282896 0.72 THRB (0.51) L3MBTL1MAPTKMT2AALDH1A1MEN1
SCHEMBL5282900 0.72 THRB (0.51) L3MBTL1MAPTKMT2AALDH1A1MEN1
SCHEMBL11462221 0.69 PSMB8 (0.52) LMNAL3MBTL1PSMB8GABRA1GABRG2
SCHEMBL4197942 0.69 LMNA (0.57) LMNAL3MBTL1MAPTKMT2AALDH1A1
SCHEMBL5288613 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT LMNA 1094/4885L3MBTL1 4878/4885PSMB8 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.